[1]
|
D. W. Sherbenou and B. J. Druker, “Applying the Discovery of the Philadelphia Chromosome,” The Journal Clinical Investigation, Vol. 117, No. 8, 2007, pp. 2067-2074. doi:10.1172/JCI31988
|
[2]
|
M. Deininger, S. G. O’Brien, F. Guilhot, J. M. Goldman, A. Hochhaus and T. P. Hughes, “International Rando-mized Study of Interferon versus STI571 (IRIS) 8-Year Follow-Up: Sustained Survival and Low Risk for Pro-gression or Events in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Imatinib,” Blood (ASH Annual Meeting Ab-stracts), Vol. 114, 2009, p. 1126.
|
[3]
|
D. Marin, “Current Status of Imatinib as Frontline Therapy for Chronic Myeloid Leukemia,” Seminars Hematology, Vol. 47, No. 4, 2010, pp. 312-318.
doi:10.1053/j.seminhematol.2010.06.003
|
[4]
|
S. M. Pye, J. Cortes, P. Ault, A. Hatfield, H. Kantarjian and R. Pilot, “The Effects of Imatinib on Pregnancy Out-come,” Blood, Vol. 111, No. 12, 2008, pp. 5505-5508.
|
[5]
|
S. Cole, H. Kantarjian, P. Ault and J. E. Cortés, “Suc-cessful Completion of Pregnancy in a Patient with Chronic Myeloid Leukemia without Active Intervention: A Case Report and Review of the Literature,” Clinical Lymphoma Myeloma & Leukemia, Vol. 9, No. 4, 2009, pp. 324-347.
|
[6]
|
M. Bj?rkholm, L. Ohm and L. Stenke, “Chronic Myeloid Leukemia Presenting Late in Pregnancy. Report of a Case and a Questionnaire Reflecting Diversity in Management Options,” Annals Hematology, Vol. 88, No. 2, 2009, pp. 173-175. doi:10.1007/s00277-008-0549-x
|